Q2 2018 Holdings
Filed 2018-08-13 | 110 holdings | $71.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $19.2M | 195,232 | 26.7% |
| Biogen Inc(BIIB) | COM | 09062X103 | $14.5M | 50,000 | 20.2% |
| Cellectis S A(CLLS) | SPONSORED ADS | 15117K103 | $10.0M | 351,874 | 13.8% |
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $6.7M | 846,935 | 9.4% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $5.2M | 78,048 | 7.2% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $4.7M | 176,045 | 6.6% |
| Cisco SYS Inc(CSCO) | COM | 17275R102 | $4.3M | 100,000 | 6.0% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $3.7M | 335,987 | 5.1% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $1.9M | 83,142 | 2.6% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $589.0K | 6,250 | 0.8% |
| Charter Communications Inc N(CHTR) | CL A | 16119P108 | $416.0K | 1,419 | 0.6% |
| Spdr Series TrustPut | S&P BIOTECH | 78464A950 | $71.4K | 750,000 | 0.1% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $41.3K | 680,000 | 0.1% |
| Mylan N V | SHS EURO | N59465109 | $30.9K | 854,000 | 0.0% |
| Glaxosmithkline PLC | SPONSORED ADR | 37733W105 | $30.8K | 765,000 | 0.0% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $25.1K | 355,000 | 0.0% |
| Ishares TRPut | RUSSELL 2000 ETF | 464287955 | $24.6K | 150,000 | 0.0% |
| Shire PLC | SPONSORED ADR | 82481R106 | $21.4K | 126,500 | 0.0% |
| Alexion Pharmaceuticals Inc(ALXN) | COM | 015351109 | $19.9K | 160,544 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $19.2K | 145,096 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $18.6K | 1,189,056 | 0.0% |
| Amgen Inc(AMGN) | COM | 031162100 | $18.5K | 100,000 | 0.0% |
| Pfizer Inc(PFE) | COM | 717081103 | $14.1K | 390,000 | 0.0% |
| Clearside Biomedical Inc(CLSDUSD) | COM | 185063104 | $11.4K | 1,068,720 | 0.0% |
| Bluebird BIO Inc | COM | 09609G100 | $11.4K | 72,483 | 0.0% |
| Allergan PLC | SHS | G0177J108 | $10.0K | 60,000 | 0.0% |
| Retrophin Inc | COM | 761299106 | $9.6K | 353,072 | 0.0% |
| Arqule Inc(ARQLUSD) | COM | 04269E107 | $8.3K | 1,497,683 | 0.0% |
| Innovate Biopharmaceuticls I | COM PAR | 45782F105 | $7.8K | 980,502 | 0.0% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $7.4K | 782,424 | 0.0% |
| Microsoft Corp(MSFT) | COM | 594918104 | $7.3K | 74,435 | 0.0% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $7.3K | 306,655 | 0.0% |
| Mellanox Technologies LTD | SHS | M51363113 | $7.2K | 85,954 | 0.0% |
| Minerva Neurosciences Inc(NERVGBP) | COM | 603380106 | $6.8K | 820,120 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $6.4K | 351,953 | 0.0% |
| Sodastream International LTD | USD SHS | M9068E105 | $6.3K | 73,762 | 0.0% |
| Melinta Therapeutics Inc | COM | 58549G100 | $6.3K | 984,492 | 0.0% |
| Nice LTD(NSY) | SPONSORED ADR | 653656108 | $6.2K | 60,043 | 0.0% |
| Kadmon Hldgs Inc(KDMN) | COM | 48283N106 | $6.2K | 1,552,846 | 0.0% |
| Uniqure NV(QURE) | SHS | N90064101 | $5.8K | 152,490 | 0.0% |
| Array Biopharma Inc(ARRYEUR) | COM | 04269X105 | $5.7K | 339,804 | 0.0% |
| Adamas Pharmaceuticals Inc(ADMSEUR) | COM | 00548A106 | $5.5K | 213,625 | 0.0% |
| Biohaven Pharmactl Hldg Co L(BHVN) | COM | G11196105 | $5.4K | 137,388 | 0.0% |
| Aeglea Biotherapeutics Inc(AGLEUSD) | COM | 00773J103 | $5.4K | 509,118 | 0.0% |
| Visa Inc(V) | COM CL A | 92826C839 | $5.4K | 40,401 | 0.0% |
| Zafgen Inc | COM | 98885E103 | $4.9K | 480,000 | 0.0% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $4.8K | 136,044 | 0.0% |
| Sesen BIO Inc | COM | 817763105 | $4.6K | 2,377,068 | 0.0% |
| Wabtec Corp(WAB) | COM | 929740108 | $4.6K | 46,564 | 0.0% |
| Aerpio Pharmaceuticals Inc | COM | 00810B105 | $4.6K | 1,103,554 | 0.0% |